Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pieris Pharmaceuticals Inc (PIRS)

Pieris Pharmaceuticals Inc (PIRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Pieris Pharmaceuticals: Q3 Earnings Snapshot

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 11.71 (unch)
Pieris Pharmaceuticals (PIRS) Reports Q1 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -28.57% and 70.24%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 11.71 (unch)
MIRO : 3.39 (+0.59%)
Pieris Pharmaceuticals: Q1 Earnings Snapshot

Pieris Pharmaceuticals: Q1 Earnings Snapshot

PIRS : 11.71 (unch)
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates

AbCellera Biologics Inc. (ABCL) delivered earnings and revenue surprises of -16.67% and 6.76%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

ABCL : 3.68 (-2.65%)
PIRS : 11.71 (unch)
Pieris Pharmaceuticals (PIRS) Reports Q4 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 15.38% and 10.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 11.71 (unch)
NEO : 13.77 (-1.08%)
Acadia Healthcare (ACHC) Misses Q4 Earnings Estimates

Acadia Healthcare (ACHC) delivered earnings and revenue surprises of -5.41% and 2.45%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ACHC : 73.97 (+0.04%)
PIRS : 11.71 (unch)
Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is This an Indication of Further Gains?

Immunocore Holdings PLC Sponsored ADR (IMCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher...

IMCR : 59.13 (+0.08%)
PIRS : 11.71 (unch)
Pieris Pharmaceuticals (PIRS) Reports Q3 Loss, Tops Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of 18.75% and 19.04%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

PIRS : 11.71 (unch)
AVEO : 15.00 (unch)
Pieris Pharmaceuticals: Q3 Earnings Snapshot

Pieris Pharmaceuticals: Q3 Earnings Snapshot

PIRS : 11.71 (unch)
Pieris Pharmaceuticals (PIRS) Reports Q2 Loss, Lags Revenue Estimates

Pieris Pharmaceuticals (PIRS) delivered earnings and revenue surprises of -27.27% and 64.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PIRS : 11.71 (unch)
IBRX : 8.21 (+2.75%)

Barchart Exclusives

Is MicroStrategy Headed for S&P 500 Eligibility?
MicroStrategy is a tech stock with significant exposure to Bitcoin, tying its share prices to the digital asset. However, one analyst thinks MSTR should be targeting the benchmark S&P 500 Index. Let's see why. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar